Overview

Treating Early Stage Diabetic Retinopathy

Status:
Not yet recruiting

Trial end date:
2028-12-31

Target enrollment:

Participant gender:

Summary

To determine if levodopa will slow the appearance of blood vessel changes in the eyes of patients with diabetes. Treatment will be started in patients with diabetes show delays in the electrical activity of the retina when measured non-invasively with a electroretinogram.

Phase:

Early Phase 1

Details

Lead Sponsor:

VA Office of Research and Development

Collaborator:

Emory University

Treatments:

Carbidopa, levodopa drug combination
Levodopa